{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:42:40Z","timestamp":1790836960483,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011284","name":"Valeant","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011284","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An obesity paradox has been described in relation to adverse clinical outcomes (e.g., mortality) with lower body mass index (BMI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>We sought to evaluate the association between BMI and weight loss with long-term all-cause mortality in adult populations under the care of family physicians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>LIPIDOGRAM studies were conducted in primary care in Poland in 2004, 2006, and 2015 and enrolled a total of 45,615 patients. The LIPIDOGRAM Plus study included 1627 patients recruited in the LIPIDOGRAM 2004 and repeated measurements in 2006 edition. Patients were classified by BMI categories as underweight, normal weight, overweight and class I, II, or III (obesity). Follow-up data up to December 2021 were obtained from the Central Statistical Office. Differences in all-cause mortality were analyzed using Kaplan\u2012Meier and Cox regression analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 45,615 patients, 10,987 (24.1%) were normal weight, 320 (0.7%) were underweight, 19,134 (41.9%) were overweight, and 15,174 (33.2%) lived with obesity. Follow-up was available for 44,620 patients (97.8%, median duration 15.3 years, 61.7% females). In the crude analysis, long-term all-cause mortality was lowest for the normal-weight group (14%) compared with other categories. After adjusting for comorbidities, the highest risk of death was observed for the class III obesity and underweight categories (hazard ratio, HR 1.79, 95% CI [1.55\u20132.05] and HR 1.57, 95% CI [1.22\u20132.04]), respectively. The LIPIDOGRAM Plus analysis revealed that a decrease in body weight (by 5 and 10%) over 2 years was associated with a significantly increased risk of death during long-term follow-up\u2014HR 1.45 (95% CI 1.05\u20132.02, <jats:italic>p<\/jats:italic>\u2009=\u20090.03) and HR 1.67 (95% CI 1.02\u20132.74, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Patients who experienced weight loss were older and more burdened with comorbidities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Being underweight, overweight or obese is associated with a higher mortality risk in a population of patients in primary care. Patients who lost weight were older and more burdened with cardiometabolic diseases, which may suggest unintentional weight loss, and were at higher risk of death in the long-term follow-up. In nonsmoking patients without comorbidities, the lowest mortality was observed in those with a BMI\u2009&lt;\u200925\u00a0kg\/m<jats:sup>2<\/jats:sup>, and no U-curve relationship was observed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-02059-0","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:02:26Z","timestamp":1701180146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004\u20132015 cohort studies: no obesity paradox?"],"prefix":"10.1186","volume":"22","author":[{"given":"Tadeusz","family":"Osadnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Osadnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Gierlotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Windak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Mastej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"\u0141abuz-Roszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacper","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Go\u0142awski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the LIPIDOGRAM Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"issue":"5","key":"2059_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1056\/NEJMOA020245","volume":"347","author":"S Kenchaiah","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):59\u201360. https:\/\/doi.org\/10.1056\/NEJMOA020245.","journal-title":"N Engl J Med"},{"issue":"13","key":"2059_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1056\/NEJM199003293221303","volume":"322","author":"JE Manson","year":"2010","unstructured":"Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 2010;322(13):882\u20139. https:\/\/doi.org\/10.1056\/NEJM199003293221303.","journal-title":"N Engl J Med"},{"issue":"12","key":"2059_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-028638","volume":"9","author":"M Yousufuddin","year":"2019","unstructured":"Yousufuddin M, Takahashi PY, Major B, et al. Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis. BMJ Open. 2019;9(12):1\u201312. https:\/\/doi.org\/10.1136\/bmjopen-2018-028638.","journal-title":"BMJ Open"},{"issue":"1","key":"2059_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/J.1467-789X.2006.00248.X","volume":"8","author":"I Janssen","year":"2007","unstructured":"Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev. 2007;8(1):41\u201359. https:\/\/doi.org\/10.1111\/J.1467-789X.2006.00248.X.","journal-title":"Obes Rev"},{"issue":"7630","key":"2059_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/BMJ.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134\u20139. https:\/\/doi.org\/10.1136\/BMJ.39367.495995.AE.","journal-title":"BMJ"},{"key":"2059_CR6","unstructured":"Banach M, Burchardt P, Chlebus K, et al. WYTYCZNE PTL\/KLRwP\/PTK\/ PTDL\/PTD\/PTNT DIAGNOSTYKI I LECZENIA ZABURZE\u0143 LIPIDOWYCH W POLSCE 2021. Lekarz POZ Suplement. Published online 2021. https:\/\/www.termedia.pl\/WYTYCZNE-PTL-KLRwP-PTK-r-nPTDL-PTD-PTNT-DIAGNOSTYKI-r-nI-LECZENIA-ZABURZEN-r-nLIPIDOWYCH-W-POLSCE-2021,166,45338,1,1.html"},{"key":"2059_CR7","unstructured":"Global InfoBase W. The SuRF Report 2 Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates The SuRF Report 2 CD-rom included The SuRF Report 2-Country-level data and comparable estimates."},{"issue":"10113","key":"2059_CR8","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"J Bentham","year":"2017","unstructured":"Bentham J, Di Cesare M, Bilano V, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390(10113):2627\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(17)32129-3.","journal-title":"Lancet"},{"issue":"14","key":"2059_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/J.JACC.2014.01.022","volume":"63","author":"CJ Lavie","year":"2014","unstructured":"Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345\u201354. https:\/\/doi.org\/10.1016\/J.JACC.2014.01.022.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2059_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/07853890.2016.1197415","volume":"48","author":"K Alagiakrishnan","year":"2016","unstructured":"Alagiakrishnan K, Banach M, Ahmed A, Aronow WS. Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure. Ann Med. 2016;48(8):603\u201313. https:\/\/doi.org\/10.1080\/07853890.2016.1197415.","journal-title":"Ann Med"},{"key":"2059_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5114\/aoms\/152921","volume":"16","author":"P Dobrowolski","year":"2022","unstructured":"Dobrowolski P, Prejbisz A, Kury\u0142owicz A, et al. Guidelines\/Recommendations Metabolic Syndrome Metabolic syndrome-a new definition and management guidelines. Agnieszka Mastalerz-Migas. 2022;16:24. https:\/\/doi.org\/10.5114\/aoms\/152921.","journal-title":"Agnieszka Mastalerz-Migas"},{"key":"2059_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad101","author":"K Osadnik","year":"2023","unstructured":"Osadnik K, Osadnik T, Gierlotka M, et al. Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004\u20132015 cohort studies. Eur J Prev Cardiol. 2023. https:\/\/doi.org\/10.1093\/eurjpc\/zwad101.","journal-title":"Eur J Prev Cardiol"},{"key":"2059_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0086837","author":"BM Kaess","year":"2014","unstructured":"Kaess BM, J\u00f3\u017awiak J, Nelson CP, et al. The relation of rapid changes in obesity measures to lipid profile\u2014insights from a nationwide metabolic health survey in 444 Polish cities. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0086837.","journal-title":"PLoS ONE"},{"key":"2059_CR14","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.96052","author":"J J\u00f3\u017awiak","year":"2020","unstructured":"J\u00f3\u017awiak J, Kasperczyk S, Tomasik T, et al. Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies. Arch Med Sci. 2020. https:\/\/doi.org\/10.5114\/aoms.2020.96052.","journal-title":"Arch Med Sci"},{"issue":"16","key":"2059_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"issue":"39","key":"2059_CR16","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/EURHEARTJ\/EHT108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035\u201387. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHT108.","journal-title":"Eur Heart J"},{"issue":"5","key":"2059_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16(5):442\u20133. https:\/\/doi.org\/10.1046\/j.1464-5491.1999.00059.x.","journal-title":"Diabet Med"},{"key":"2059_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0021-9150(03)00419-2","volume":"173","author":"G De","year":"2004","unstructured":"De G, Ambrosioni E, Borch-Johnsen K, et al. Executive summary European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis. 2004;173:381\u201391. https:\/\/doi.org\/10.1016\/S0021-9150(03)00419-2.","journal-title":"Atherosclerosis"},{"issue":"19","key":"2059_CR19","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/JAMA.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372. https:\/\/doi.org\/10.1001\/JAMA.289.19.2560.","journal-title":"JAMA"},{"issue":"18","key":"2059_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1001\/jama.2016.4666","volume":"315","author":"S Afzal","year":"2016","unstructured":"Afzal S, Tybj\u00e6rg-Hansen A, Jensen GB, Nordestgaard BG. Change in body mass index associated with lowest mortality in Denmark, 1976\u20132013. JAMA. 2016;315(18):1989\u201396. https:\/\/doi.org\/10.1001\/jama.2016.4666.","journal-title":"JAMA"},{"issue":"9536","key":"2059_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"A Romero-Corral","year":"2006","unstructured":"Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(06)69251-9.","journal-title":"Lancet"},{"issue":"11","key":"2059_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/S10654-014-9961-9","volume":"29","author":"J Niedziela","year":"2014","unstructured":"Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801\u201312. https:\/\/doi.org\/10.1007\/S10654-014-9961-9.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"2059_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/S40519-020-01015-1","volume":"26","author":"G Gravina","year":"2021","unstructured":"Gravina G, Ferrari F, Nebbiai G. The obesity paradox and diabetes. Eat Weight Disord. 2021;26(4):1057\u201368. https:\/\/doi.org\/10.1007\/S40519-020-01015-1.","journal-title":"Eat Weight Disord"},{"key":"2059_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2023.03.038","volume":"380","author":"C Gurevitz","year":"2023","unstructured":"Gurevitz C, Assali A, Mohsan J, et al. The obesity paradox in patients with acute coronary syndromes over 2 decades\u2014the ACSIS registry 2000\u20132018. Int J Cardiol. 2023;380:48\u201355. https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.038.","journal-title":"Int J Cardiol"},{"issue":"6","key":"2059_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/hrt.2008.150524","volume":"95","author":"M Khalangot","year":"2009","unstructured":"Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95(6):454. https:\/\/doi.org\/10.1136\/hrt.2008.150524.","journal-title":"Heart"},{"issue":"2","key":"2059_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/J.PCAD.2018.05.005","volume":"61","author":"TB Horwich","year":"2018","unstructured":"Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61(2):151\u20136. https:\/\/doi.org\/10.1016\/J.PCAD.2018.05.005.","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"2059_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/S13668-019-00280-6","volume":"8","author":"DH Lee","year":"2019","unstructured":"Lee DH, Giovannucci EL. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr Nutr Rep. 2019;8(3):175\u201381. https:\/\/doi.org\/10.1007\/S13668-019-00280-6.","journal-title":"Curr Nutr Rep"},{"issue":"5","key":"2059_CR28","first-page":"517","volume":"58","author":"GB Shaw","year":"2012","unstructured":"Shaw GB, Bosomworth NJ, Fcfp C. The downside of weight loss: realistic intervention in body-weight trajectory. Can Fam Physician. 2012;58(5):517.","journal-title":"Can Fam Physician"},{"issue":"9669","key":"2059_CR29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"Prospective Studies Collaboration","year":"2009","unstructured":"Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(09)60318-4.","journal-title":"Lancet"},{"issue":"8","key":"2059_CR30","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/S00392-021-01822-1","volume":"110","author":"N Marcks","year":"2021","unstructured":"Marcks N, Aimo A, Januzzi JL, et al. Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data. Clin Res Cardiol. 2021;110(8):1280\u201391. https:\/\/doi.org\/10.1007\/S00392-021-01822-1.","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"2059_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000356760","volume":"60","author":"S Ali","year":"2014","unstructured":"Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options\u2014a mini-review. Gerontology. 2014;60(4):294\u2013305. https:\/\/doi.org\/10.1159\/000356760.","journal-title":"Gerontology"},{"issue":"36","key":"2059_CR32","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/EURHEARTJ\/EHAB368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB368.","journal-title":"Eur Heart J"},{"issue":"14","key":"2059_CR33","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/JAMA.2009.454","volume":"301","author":"CM O\u2019Connor","year":"2009","unstructured":"O\u2019Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439\u201350. https:\/\/doi.org\/10.1001\/JAMA.2009.454.","journal-title":"JAMA"},{"issue":"12","key":"2059_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/J.JACC.2018.12.072","volume":"73","author":"RS Taylor","year":"2019","unstructured":"Taylor RS, Walker S, Smart NA, et al. Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol. 2019;73(12):1430\u201343. https:\/\/doi.org\/10.1016\/J.JACC.2018.12.072.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2059_CR35","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jcsm.12980","volume":"13","author":"S Prausm\u00fcller","year":"2022","unstructured":"Prausm\u00fcller S, Heitzinger G, Pavo N, et al. Malnutrition outweighs the effect of the obesity paradox. J Cachexia Sarcopenia Muscle. 2022;13(3):1477\u201386. https:\/\/doi.org\/10.1002\/jcsm.12980.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2059_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S0954422409990035","volume":"22","author":"M Harrington","year":"2009","unstructured":"Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev. 2009;22(1):93\u2013108. https:\/\/doi.org\/10.1017\/S0954422409990035.","journal-title":"Nutr Res Rev"},{"key":"2059_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJMED.2012.11.024","author":"TF Overvad","year":"2013","unstructured":"Overvad TF, Rasmussen LH, Skj\u00f8th F, Overvad K, Lip GYH, Larsen TB. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med. 2013. https:\/\/doi.org\/10.1016\/J.AMJMED.2012.11.024.","journal-title":"Am J Med"},{"issue":"4","key":"2059_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/EHF2.12237","volume":"4","author":"J Springer","year":"2017","unstructured":"Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017;4(4):492\u20138. https:\/\/doi.org\/10.1002\/EHF2.12237.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"2059_CR39","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/EJHF.1304","volume":"20","author":"A Emami","year":"2018","unstructured":"Emami A, Saitoh M, Valentova M, et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail. 2018;20(11):1580\u20137. https:\/\/doi.org\/10.1002\/EJHF.1304.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2059_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/S13679-017-0262-Y","volume":"6","author":"DH Ryan","year":"2017","unstructured":"Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187. https:\/\/doi.org\/10.1007\/S13679-017-0262-Y.","journal-title":"Curr Obes Rep"},{"issue":"5","key":"2059_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/OBY.2006.84","volume":"14","author":"TA Wadden","year":"2006","unstructured":"Wadden TA. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14(5):737. https:\/\/doi.org\/10.1038\/OBY.2006.84.","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2059_CR42","doi-asserted-by":"publisher","first-page":"0510","DOI":"10.1371\/JOURNAL.PMED.0020171","volume":"2","author":"TIA S\u00f8rensen","year":"2005","unstructured":"S\u00f8rensen TIA, Rissanen A, Korkeila M, Kaprio J. Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities. PLoS Med. 2005;2(6):0510\u201320. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.0020171.","journal-title":"PLoS Med"},{"issue":"8","key":"2059_CR43","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/DOM.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364. https:\/\/doi.org\/10.1111\/DOM.14725.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2059_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12933-022-01503-x","volume":"21","author":"S Huang","year":"2022","unstructured":"Huang S, Shi K, Ren Y, et al. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):78. https:\/\/doi.org\/10.1186\/s12933-022-01503-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2059_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12933-022-01706-2","volume":"21","author":"E Orsi","year":"2022","unstructured":"Orsi E, Solini A, Penno G, et al. Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):266. https:\/\/doi.org\/10.1186\/s12933-022-01706-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"12 Pt 1","key":"2059_CR46","first-page":"5940","volume":"44","author":"LA Loeb","year":"1984","unstructured":"Loeb LA, Ernster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 1984;44(12 Pt 1):5940\u201358.","journal-title":"Cancer Res"},{"issue":"5","key":"2059_CR47","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/IJE\/DYP289","volume":"38","author":"J Cornfield","year":"2009","unstructured":"Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. Int J Epidemiol. 2009;38(5):1175\u201391. https:\/\/doi.org\/10.1093\/IJE\/DYP289.","journal-title":"Int J Epidemiol"},{"key":"2059_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0123579","author":"S Dare","year":"2015","unstructured":"Dare S, Mackay DF, Pell JP. Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0123579.","journal-title":"PLoS ONE"},{"key":"2059_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0148926","author":"T Watanabe","year":"2016","unstructured":"Watanabe T, Tsujino I, Konno S, et al. Association between smoking status and obesity in a nationwide survey of Japanese adults. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0148926.","journal-title":"PLoS ONE"},{"issue":"5","key":"2059_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0306-4603(98)00014-8","volume":"23","author":"B Borrelli","year":"1998","unstructured":"Borrelli B, Mermelstein R. The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program. Addict Behav. 1998;23(5):609\u201322. https:\/\/doi.org\/10.1016\/S0306-4603(98)00014-8.","journal-title":"Addict Behav"},{"key":"2059_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.I5855","author":"N Veronese","year":"2016","unstructured":"Veronese N, Li Y, Manson JE, Willett WC, Fontana L, Hu FB. Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study. BMJ. 2016. https:\/\/doi.org\/10.1136\/BMJ.I5855.","journal-title":"BMJ"},{"issue":"4","key":"2059_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/EDE.0000000000000493","volume":"27","author":"M Sperrin","year":"2016","unstructured":"Sperrin M, Candlish J, Badrick E, Renehan A, Buchan I. Collider bias is only a partial explanation for the obesity paradox. Epidemiology. 2016;27(4):525. https:\/\/doi.org\/10.1097\/EDE.0000000000000493.","journal-title":"Epidemiology"},{"issue":"8","key":"2059_CR53","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ijo.2017.99","volume":"41","author":"HR Banack","year":"2017","unstructured":"Banack HR, Stokes A. The \u2018obesity paradox\u2019 may not be a paradox at all. Int J Obes. 2017;41(8):1162\u20133. https:\/\/doi.org\/10.1038\/ijo.2017.99.","journal-title":"Int J Obes"},{"key":"2059_CR54","doi-asserted-by":"publisher","first-page":"101356","DOI":"10.1016\/j.eeh.2020.101356","volume":"78","author":"EB Schneider","year":"2020","unstructured":"Schneider EB. Collider bias in economic history research. Explor Econ Hist. 2020;78:101356. https:\/\/doi.org\/10.1016\/j.eeh.2020.101356.","journal-title":"Explor Econ Hist"},{"key":"2059_CR55","doi-asserted-by":"publisher","first-page":"i1246","DOI":"10.1136\/bmj.i1246","volume":"353","author":"CE Ramsden","year":"2016","unstructured":"Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968\u201373). BMJ. 2016;353:i1246. https:\/\/doi.org\/10.1136\/bmj.i1246.","journal-title":"BMJ"},{"key":"2059_CR56","doi-asserted-by":"publisher","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u20132559. https:\/\/doi.org\/10.1056\/NEJMoa0802743","DOI":"10.1056\/NEJMoa0802743"},{"key":"2059_CR57","doi-asserted-by":"publisher","first-page":"111096","DOI":"10.1016\/j.mehy.2023.111096","volume":"176","author":"M Pavlov","year":"2023","unstructured":"Pavlov M, Nikolic-Heitzler V. Obesity paradox in acute myocardial infarction: is plasminogen activator inhibitor 1 the culprit? Med Hypotheses. 2023;176:111096. https:\/\/doi.org\/10.1016\/j.mehy.2023.111096.","journal-title":"Med Hypotheses"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:03:02Z","timestamp":1701180182000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02059-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human subjects complied with all relevant national regulations and institutional policies, was in accordance with the Helsinki Declaration (as revised in 2013), and was approved by the Bioethical Committee of the Chamber of Physicians (No.K.B.Cz.-0018\/ 2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: J.J. and M.B. have received an unrestricted educational grant from Valeant and have served as consultants or speakers for Valeant. P.T. owns four shares in AstraZeneca PLC and has received honoraria and\/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, Napp, and Sanofi. All other authors declare no conflicts of interest concerning the results of this analysis. All authors revised the article critically for important intellectual content. All authors gave final approval of the work, have participated sufficiently in the work, and take public responsibility for appropriate portions of the content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}